CH676990A5 - - Google Patents

Download PDF

Info

Publication number
CH676990A5
CH676990A5 CH4680/86A CH468086A CH676990A5 CH 676990 A5 CH676990 A5 CH 676990A5 CH 4680/86 A CH4680/86 A CH 4680/86A CH 468086 A CH468086 A CH 468086A CH 676990 A5 CH676990 A5 CH 676990A5
Authority
CH
Switzerland
Prior art keywords
superoxide dismutase
human
sep
mnsod
plasmid
Prior art date
Application number
CH4680/86A
Other languages
German (de)
English (en)
Inventor
Jacob R Hartmann
Yaffa Beck
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of CH676990A5 publication Critical patent/CH676990A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CH4680/86A 1985-11-22 1986-11-21 CH676990A5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80109085A 1985-11-22 1985-11-22
US90705186A 1986-09-12 1986-09-12

Publications (1)

Publication Number Publication Date
CH676990A5 true CH676990A5 (da) 1991-03-28

Family

ID=27122291

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4680/86A CH676990A5 (da) 1985-11-22 1986-11-21

Country Status (21)

Country Link
JP (2) JP2609449B2 (da)
AT (1) AT400443B (da)
AU (1) AU607897B2 (da)
BE (1) BE905796A (da)
CA (1) CA1341362C (da)
CH (1) CH676990A5 (da)
DE (1) DE3639725C2 (da)
DK (1) DK534686A (da)
ES (1) ES2003518A6 (da)
FI (1) FI90353C (da)
FR (1) FR2590591B1 (da)
GB (1) GB2183658B (da)
GR (1) GR862713B (da)
HK (1) HK75195A (da)
IE (1) IE59498B1 (da)
IL (2) IL106449A (da)
IT (1) IT1205418B (da)
LU (1) LU86676A1 (da)
NL (1) NL8602960A (da)
PT (1) PT83792B (da)
SE (1) SE8604884L (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0587055A1 (de) * 1992-09-09 1994-03-16 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verwendung von Mangan-Superoxiddismutase (Mn-SOD) zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen in niedriger Dosierung

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610520B1 (en) * 1985-11-22 2003-08-26 Bio-Technology General Corp. Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
JPS62215532A (ja) * 1986-03-18 1987-09-22 Ube Ind Ltd 抗炎症剤
JPH0643341B2 (ja) * 1986-03-27 1994-06-08 宇部興産株式会社 臓器機能改善剤
JPH0643340B2 (ja) * 1986-09-03 1994-06-08 宇部興産株式会社 虚血性心疾患治療薬
JPS6377822A (ja) * 1986-09-18 1988-04-08 Ube Ind Ltd 臓器機能改善剤
US6326003B1 (en) 1986-10-14 2001-12-04 Chiron Corporation Manganese superoxide dismutase cloning and expression in microorganisms
EP0676472A1 (de) * 1987-03-14 1995-10-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Humane Mangan-Superoxiddismutase (hMn-SOD)
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
EP0284105B1 (en) * 1987-03-27 1995-11-15 Bio-Technology General Corporation Human manganese superoxide dismutase and methods of treatment
JPH01233228A (ja) * 1988-03-11 1989-09-19 Toyo Jozo Co Ltd 悪性腫瘍細胞転移防止剤
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
DE4038563A1 (de) * 1990-12-04 1992-06-11 Gruenenthal Gmbh Verwendung von superoxiddismutasen zur prophylaxe und/oder behandlung von organversagen bei risikopatienten mit polytrauma
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56102787A (en) * 1980-01-18 1981-08-17 Mamoru Sugiura Preparation of human placenta superoxide dismutase
BG49718A3 (en) * 1983-07-15 1992-01-15 Bio- Technology General Corp Method for preparing of polypeptid with superoxiddismutasne activitty
EP0656418B1 (en) * 1983-10-03 2002-12-04 Chiron Corporation Superoxide dismutase and expression in microorganisms

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0587055A1 (de) * 1992-09-09 1994-03-16 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verwendung von Mangan-Superoxiddismutase (Mn-SOD) zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen in niedriger Dosierung

Also Published As

Publication number Publication date
GB2183658B (en) 1990-04-25
PT83792B (pt) 1989-01-17
BE905796A (fr) 1987-03-16
ES2003518A6 (es) 1988-11-01
HK75195A (en) 1995-05-26
AU6497586A (en) 1987-05-28
PT83792A (en) 1986-12-01
GB2183658A (en) 1987-06-10
AU607897B2 (en) 1991-03-21
IL80702A0 (en) 1987-02-27
CA1341362C (en) 2002-05-28
IT8667865A0 (it) 1986-11-21
DK534686D0 (da) 1986-11-07
JP2967557B2 (ja) 1999-10-25
GR862713B (en) 1987-03-24
FI864756A (fi) 1987-05-23
IL106449A (en) 1997-02-18
IT1205418B (it) 1989-03-15
IE862851L (en) 1987-05-22
SE8604884D0 (sv) 1986-11-14
JPH08289792A (ja) 1996-11-05
FI90353C (fi) 1994-01-25
IL106449A0 (en) 1993-11-15
NL8602960A (nl) 1987-06-16
FR2590591A1 (fr) 1987-05-29
GB8627294D0 (en) 1986-12-17
FI864756A0 (fi) 1986-11-21
JPS62289187A (ja) 1987-12-16
JP2609449B2 (ja) 1997-05-14
ATA308986A (de) 1995-05-15
DK534686A (da) 1987-05-23
FI90353B (fi) 1993-10-15
FR2590591B1 (fr) 1989-12-01
AT400443B (de) 1995-12-27
SE8604884L (sv) 1987-05-23
LU86676A1 (fr) 1987-05-04
DE3639725C2 (de) 1998-02-19
DE3639725A1 (de) 1987-07-23
IE59498B1 (en) 1994-03-09

Similar Documents

Publication Publication Date Title
DE60029091T2 (de) Verfahren zur herstellung von diphtheria toxin
EP0282899B1 (de) Humane Mangan-Superoxiddismutase (hMn-SOD)
DE3486425T2 (de) Wachstumshormon-Analoga, pharmazeutische und veterinäre Zusammensetzungen, die diese enthalten, sowie Methoden für ihre Herstellung
DE3854678T2 (de) Menschliches Mangansuperoxiddismutase und Behandlungsverfahren.
DE3785864T2 (de) Verfahren zur Herstellung von menschlichem Epidermalwachstumsfaktor und dessen Analogen.
DE69020573T3 (de) Verfahren zur wachstumshemmung von stammzellen.
AT400443B (de) Menschliche mangan-superoxiddismutase cdna, ihre expression in bakterien und verfahren zur gewinnung enzymatisch aktiver, menschlicher mangan-superoxiddismutase
DD299318A5 (de) Gereinigter ziliarer neurotrophischer faktor
DE69027383T2 (de) Neue superoxyd-dismutase
DE69535704T2 (de) EXPRESSIONSPLASMIDE, DURCH EINEN osmB PROMOTER REGULIERT
DE3712985A1 (de) Bifunktionelle proteine
DE19535853C2 (de) Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3588216T2 (de) Methode ein enzymatisch aktives Polypeptidanalog des menschlichen Cu/Zn SOD herzustellen
DE3855078T2 (de) Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode
DE3852870T2 (de) Saurer Fibroblast-Wachstumsfaktor-Mutant.
DE3880511T2 (de) Thermostabile menschliche cu/zn-superoxid-dismutase-muteine.
DE69331368T2 (de) Herstellung und Benützung eines Metastasehemmendes Proteines.
US6361772B1 (en) Human manganese superoxide dismutase DNA, its expression and method of recovering human manganese superoxide dismutase
US5246847A (en) Polypeptide analogs of human manganese superoxide dismutase and compositions and complexes thereof
DE3884853T2 (de) Angiogenininhibitoren.
DE68923613T2 (de) Superoxid-dismutaseanaloge mit neuen bindeeigenschaften.
EP0244627A2 (de) Expressionsvektoren zur Gewinnung von Polypeptiden
DE3586926T2 (de) Schweinepankreas-elastase.
DE69011465T2 (de) Verwendung von Human-ADF (=Adult T-cell leukemia-derived factor) zur Herstellung von Medikamenten.
DE69430326T2 (de) Superoxid dismutase-4

Legal Events

Date Code Title Description
PL Patent ceased